A National Cancer Institute-designated Comprehensive Cancer Center

Make an appointment: 800-826-HOPE
How the Experts Treat Kidney Cancer Bookmark and Share

How the Experts Treat Kidney Cancer

Release date: November 22, 2011
Estimated time to complete activity: 1.25 hours

To obtain CME credit: 
 
  • Complete the evaluation form
  • Submit to CME department via
    • Fax - 626-301-8939 or
    • Email - cme@coh.org or
    • Standard mail - 1500 E. Duarte Rd., Building 94, Duarte, CA 91010
 
  • Questions:626-256-4673, ext. 65622
 
Additional Resources:

Reading List

In the US, renal cell cancer (RCC) accounts for about 3% of all adult cancers. NCI data indicate that an estimated 58,000 new cases of kidney cancer were diagnosed in 2010, and approximately 13,000 Americans died of the disease. Surgery to remove the affected kidney is the most common initial treatment for all stages of kidney cancer. However, regionally advanced or metastatic cases account for approximately half of all new cases. Historically survival rates for these patient populations have been about 20%. This poor prognosis combined with modest efficacy and high toxicity associated with currently available therapies for RCC has necessitated and resulted in the development of newer targeted therapies in order to improve outcome in these patient groups. This activity has been designed to provide the health care professional with the most current clinical and investigative data pertaining to new less invasive surgical techniques for the primary management of RCC and the expanding role of emerging multi-targeted therapies for patients with regionally advanced or metastatic RCC.

Upon successful completion of this activity, the learner should be better able to:
  • Review "traditional" and less invasive surgical techniques for the management of kidney cancer
  • Examine how new multi-targeted therapies beneficially impact the management of metastatic kidney cancer
  • Discuss current therapeutic approaches to the treatment of metastatic kidney cancer
  • Describe the multidisciplinary treatment paradigm for the treatment of kidney cancer

 

This activity has been designed to meet the needs of medical oncologists, urologists, internists and allied health care providers who treat patients with kidney cancer.
 

City of Hope is accredited by the Accreditation Council for Continuing Medical education to provide continuing medical education for physicians.
City of Hope designates this live activity for a maximum of 1.25 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.


The following may apply CME Category 1 credit for license renewal:
 
  • Registered Nurses: Nurses may report up to 1.25 credit hours toward the continuing education requirements for license renewal by their state Board of Registered Nurses (BRN). CME may be noted on the license renewal application in lieu of a BRN provider number.
  • Physician’s Assistants:The National Commission on certification of Physicians Assistants states that AMA accredited Category 1 courses are acceptable fro CME requirements for recertification.
  •  
  • To receive CME credit, it is necessary to complete the post test & evaluation form. For more information,please click here.
  •  
  • City of Hope has implemented policies and procedures to be in strict compliance with current ACCME Standards of Commercial Support requiring disclosure and resolution conflicts of interest.

 

Faculty Disclosure:
As part of these new commercial guidelines, we are required to disclose if Faculty , Presenters, Authors, Planners, CME Committee Members, Course Directors and / or Moderators have any real or apparent vested commercial interest(s) in both those companies whose products may be discussed/described during the course of the activity and in those companies who may be acting as commercial supporters of the activity.

Disclosure of Off-Label Use:
This activity may contain discussion of published and/or investigational uses of agents that are not approved/indicated by the US Food and Drug Administration (FDA).

 
 

Disclaimer

The City of Hope presents this resource for educational purposes only. Participants have an implied responsibility to use the newly acquired information to enhance patient outcomes and their own professional development.

The views and opinions expressed in these presentations are those of the authors and do not necessarily reflect the views of City of Hope and/or the activity educational grant supporters.

City of Hope and/or its agents shall not be responsible or in any way liable for the continued currency of the information or for any errors, omissions, or inaccuracies in this publication, whether arising from negligence or otherwise howsoever or for any consequences arising there from.

Cultural and Linguistic Competency

The California legislature has passed AB 1195 which states that as of July 1, 2006 all Category 1 CME activities that relate to patient care must include a cultural diversity/linguistics component.

Definitions:Cultural competency means a set of integrated attitudes, knowledge, and skills that enables a health care professional or organization to care effectively for patients from diverse cultures, groups, and communities. Linguistic competency means the ability of a physician and surgeon to provide patients who do not speak English or who have limited ability to speak English, direct communication in the patient's primary language.

Faculty have been asked to include in their educational content relevant cultural diversity information relating to age, gender, race, socio-economics, sexual orientation, religion, language, ethnicity, etc. that impacts the care of the patient.

Core Competencies

The American Board of Medical Specialties ( ABMS ) and the Accreditation Council of Graduate Medical Education (ACGME) have embarked on a joint initiative to quantify and evaluate a set of 6 physician core competencies by which the individual physician will be measured for Residency Certification, Board Certification and more recently, Maintenance of Certification (MOC).

In brief the actual term “core competencies” refers to those 6 abilities (competencies) that are central (core) to the practice of medicine, specifically:

Patient Care Medical Knowledge Practice-Based Learning and Improvement Interpersonal and Communication Skills Professionalism Systems-Based PracticeDr. Smita Bhatia has indicated that that the education content of this presentation will provide information and insight on Core Competencies #1 Patient Care, #2 Medical Knowledge, #3 Practice-Based Learning and Improvement, #4 Interpersonal and Communication Skills, #5 Professionalismand #6 Systems-Based Practice.

The CME certificate for this activity will reflect those core competencies addressed.

Contact CME

For additional information or questions about this module, please contact:

Crystal Saavedra, Assistant Manager
Department of Continuing Medical Education
City of Hope
Module 94, Room 1006
1500 East Duarte Road
Duarte, CA 91010

E-mail:csaavedra@coh.org
Fax: 626-301-8939
Phone: 626-256-4673, ext. 64566

CME Credit

Instructions:
Complete Post Test & Evaluation Form by clicking here. E-mail tocme@coh.orgor fax to 626-301-8939 E-mail to or fax to 626-301-8939

Disclosures

City of Hope has implemented policies and procedures to be in strict compliance with current ACCME Standards of Commercial Support requiring disclosure and resolution conflicts of interest.
 
Faculty Disclosure:

As part of these new commercial guidelines, we are required to disclose if Faculty, Presenters, Authors, Planners, CME Committee Members, Course Directors and / or Moderators have any real or apparent vested commercial interest(s) in both those companies whose products may be discussed/described during the course of the activity and in those companies who may be acting as commercial supporters of the activity.
 
City of Hope further requires that prior to the activity Faculty have disclosed their intention to discuss any off label and/or investigational (not yet approved for any purpose) use of pharmaceutics or medical devices.
 
Dr. Lauhas indicated that he is a consultant for Intuitive Surgical and Covidien. Dr. Pal has indicated that he has received Grant/Research support from Amgen and on the Speaker's Bureau with Pfizer, Novartis and GSK and is a consultant with Novartis and Allos.
 
The following Planners and /orCMECommittee Members have indicated that they have nothing to disclose:
 
Teresa Ball, Kathleen Blazer, M.S.,Ed.D., Sandra Bolton, R.N.,J.D., Julianne Chun, Janet Crum, Ina Ervin, Jonathan Espenschied, M.D., Karl Gaal, M.D.,Jo Hanson, R.N., Fouad Kandeel, M.D., Patricia Kassab, R.N., M.S.,C.T.H.Q., Lucille Leong, M.D., Paul Lin, M.D., Matthew Loscalzo, M.S.W., Mary Mendelsohn, R.N.,M.S.N., Robert Morgan, Jr., M.D., Khanh Nguyen, M.D., Anna Pawlowska, M.D., I. Benjamin Paz, M.D., Lisa McDonald Reyes, B.S., Crystal Saavedra, B.S.and Jeffrey Weizel, M.D.
 
The following Planners and /or CMECommittee Members have declared they have the following relevant financial relationships to disclose:

Ravi Bhatia, M.D. - Consultant with Novartis& Bristol Myers Squibb, Martin Hogan, M.D. - Grant/Research Support from Johnson & Johnson, and Jean Kagan, B.A. - Stock Shareholder withAmgen/Zimmer.

Disclosure of Off-Label Use:

This activity may contain discussion of published and/or investigational uses of agents that are not approved/indicated by the US Food and Drug Administration (FDA). For additional information about approved uses, including approved indications, contraindications, and warnings, please refer to the official prescribing information for each product, or consult the Physicians’ Desk Reference. Participants from other r countries should consult with their respective regulatory authorities
 
Dr. Lau and Dr. Pal have indicated that they will not be discussing drugs that are off label or used for investigational purposes.This activity has been made possible in part by an unrestricted educational grant from Pfizer Inc.

 

 

Faculty

Clayton Lau, M.D.
Clinical Assistant Professor of Surgery
Urology and Urologic Oncology
Department of Surgery
City of Hope














Sumanta Kumar Pal, M.D.
Assistant Professor of Medical Oncology
Department of Medical Oncology and Therapeutics Research
Co-Director, Kidney Cancer Program
City of Hope








How the Experts Treat Kidney Cancer

How the Experts Treat Kidney Cancer

Release date: November 22, 2011
Estimated time to complete activity: 1.25 hours

To obtain CME credit: 
 
  • Complete the evaluation form
  • Submit to CME department via
    • Fax - 626-301-8939 or
    • Email - cme@coh.org or
    • Standard mail - 1500 E. Duarte Rd., Building 94, Duarte, CA 91010
 
  • Questions:626-256-4673, ext. 65622
 
Additional Resources:

Reading List

In the US, renal cell cancer (RCC) accounts for about 3% of all adult cancers. NCI data indicate that an estimated 58,000 new cases of kidney cancer were diagnosed in 2010, and approximately 13,000 Americans died of the disease. Surgery to remove the affected kidney is the most common initial treatment for all stages of kidney cancer. However, regionally advanced or metastatic cases account for approximately half of all new cases. Historically survival rates for these patient populations have been about 20%. This poor prognosis combined with modest efficacy and high toxicity associated with currently available therapies for RCC has necessitated and resulted in the development of newer targeted therapies in order to improve outcome in these patient groups. This activity has been designed to provide the health care professional with the most current clinical and investigative data pertaining to new less invasive surgical techniques for the primary management of RCC and the expanding role of emerging multi-targeted therapies for patients with regionally advanced or metastatic RCC.

Upon successful completion of this activity, the learner should be better able to:
  • Review "traditional" and less invasive surgical techniques for the management of kidney cancer
  • Examine how new multi-targeted therapies beneficially impact the management of metastatic kidney cancer
  • Discuss current therapeutic approaches to the treatment of metastatic kidney cancer
  • Describe the multidisciplinary treatment paradigm for the treatment of kidney cancer

 

This activity has been designed to meet the needs of medical oncologists, urologists, internists and allied health care providers who treat patients with kidney cancer.
 

City of Hope is accredited by the Accreditation Council for Continuing Medical education to provide continuing medical education for physicians.
City of Hope designates this live activity for a maximum of 1.25 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.


The following may apply CME Category 1 credit for license renewal:
 
  • Registered Nurses: Nurses may report up to 1.25 credit hours toward the continuing education requirements for license renewal by their state Board of Registered Nurses (BRN). CME may be noted on the license renewal application in lieu of a BRN provider number.
  • Physician’s Assistants:The National Commission on certification of Physicians Assistants states that AMA accredited Category 1 courses are acceptable fro CME requirements for recertification.
  •  
  • To receive CME credit, it is necessary to complete the post test & evaluation form. For more information,please click here.
  •  
  • City of Hope has implemented policies and procedures to be in strict compliance with current ACCME Standards of Commercial Support requiring disclosure and resolution conflicts of interest.

 

Faculty Disclosure:
As part of these new commercial guidelines, we are required to disclose if Faculty , Presenters, Authors, Planners, CME Committee Members, Course Directors and / or Moderators have any real or apparent vested commercial interest(s) in both those companies whose products may be discussed/described during the course of the activity and in those companies who may be acting as commercial supporters of the activity.

Disclosure of Off-Label Use:
This activity may contain discussion of published and/or investigational uses of agents that are not approved/indicated by the US Food and Drug Administration (FDA).

 
 

Disclaimer

Disclaimer

The City of Hope presents this resource for educational purposes only. Participants have an implied responsibility to use the newly acquired information to enhance patient outcomes and their own professional development.

The views and opinions expressed in these presentations are those of the authors and do not necessarily reflect the views of City of Hope and/or the activity educational grant supporters.

City of Hope and/or its agents shall not be responsible or in any way liable for the continued currency of the information or for any errors, omissions, or inaccuracies in this publication, whether arising from negligence or otherwise howsoever or for any consequences arising there from.

Cultural and Linguistic Competency

Cultural and Linguistic Competency

The California legislature has passed AB 1195 which states that as of July 1, 2006 all Category 1 CME activities that relate to patient care must include a cultural diversity/linguistics component.

Definitions:Cultural competency means a set of integrated attitudes, knowledge, and skills that enables a health care professional or organization to care effectively for patients from diverse cultures, groups, and communities. Linguistic competency means the ability of a physician and surgeon to provide patients who do not speak English or who have limited ability to speak English, direct communication in the patient's primary language.

Faculty have been asked to include in their educational content relevant cultural diversity information relating to age, gender, race, socio-economics, sexual orientation, religion, language, ethnicity, etc. that impacts the care of the patient.

Core Competencies

Core Competencies

The American Board of Medical Specialties ( ABMS ) and the Accreditation Council of Graduate Medical Education (ACGME) have embarked on a joint initiative to quantify and evaluate a set of 6 physician core competencies by which the individual physician will be measured for Residency Certification, Board Certification and more recently, Maintenance of Certification (MOC).

In brief the actual term “core competencies” refers to those 6 abilities (competencies) that are central (core) to the practice of medicine, specifically:

Patient Care Medical Knowledge Practice-Based Learning and Improvement Interpersonal and Communication Skills Professionalism Systems-Based PracticeDr. Smita Bhatia has indicated that that the education content of this presentation will provide information and insight on Core Competencies #1 Patient Care, #2 Medical Knowledge, #3 Practice-Based Learning and Improvement, #4 Interpersonal and Communication Skills, #5 Professionalismand #6 Systems-Based Practice.

The CME certificate for this activity will reflect those core competencies addressed.

Contact CME

Contact CME

For additional information or questions about this module, please contact:

Crystal Saavedra, Assistant Manager
Department of Continuing Medical Education
City of Hope
Module 94, Room 1006
1500 East Duarte Road
Duarte, CA 91010

E-mail:csaavedra@coh.org
Fax: 626-301-8939
Phone: 626-256-4673, ext. 64566

CME Credit

CME Credit

Instructions:
Complete Post Test & Evaluation Form by clicking here. E-mail tocme@coh.orgor fax to 626-301-8939 E-mail to or fax to 626-301-8939

Disclosures

Disclosures

City of Hope has implemented policies and procedures to be in strict compliance with current ACCME Standards of Commercial Support requiring disclosure and resolution conflicts of interest.
 
Faculty Disclosure:

As part of these new commercial guidelines, we are required to disclose if Faculty, Presenters, Authors, Planners, CME Committee Members, Course Directors and / or Moderators have any real or apparent vested commercial interest(s) in both those companies whose products may be discussed/described during the course of the activity and in those companies who may be acting as commercial supporters of the activity.
 
City of Hope further requires that prior to the activity Faculty have disclosed their intention to discuss any off label and/or investigational (not yet approved for any purpose) use of pharmaceutics or medical devices.
 
Dr. Lauhas indicated that he is a consultant for Intuitive Surgical and Covidien. Dr. Pal has indicated that he has received Grant/Research support from Amgen and on the Speaker's Bureau with Pfizer, Novartis and GSK and is a consultant with Novartis and Allos.
 
The following Planners and /orCMECommittee Members have indicated that they have nothing to disclose:
 
Teresa Ball, Kathleen Blazer, M.S.,Ed.D., Sandra Bolton, R.N.,J.D., Julianne Chun, Janet Crum, Ina Ervin, Jonathan Espenschied, M.D., Karl Gaal, M.D.,Jo Hanson, R.N., Fouad Kandeel, M.D., Patricia Kassab, R.N., M.S.,C.T.H.Q., Lucille Leong, M.D., Paul Lin, M.D., Matthew Loscalzo, M.S.W., Mary Mendelsohn, R.N.,M.S.N., Robert Morgan, Jr., M.D., Khanh Nguyen, M.D., Anna Pawlowska, M.D., I. Benjamin Paz, M.D., Lisa McDonald Reyes, B.S., Crystal Saavedra, B.S.and Jeffrey Weizel, M.D.
 
The following Planners and /or CMECommittee Members have declared they have the following relevant financial relationships to disclose:

Ravi Bhatia, M.D. - Consultant with Novartis& Bristol Myers Squibb, Martin Hogan, M.D. - Grant/Research Support from Johnson & Johnson, and Jean Kagan, B.A. - Stock Shareholder withAmgen/Zimmer.

Disclosure of Off-Label Use:

This activity may contain discussion of published and/or investigational uses of agents that are not approved/indicated by the US Food and Drug Administration (FDA). For additional information about approved uses, including approved indications, contraindications, and warnings, please refer to the official prescribing information for each product, or consult the Physicians’ Desk Reference. Participants from other r countries should consult with their respective regulatory authorities
 
Dr. Lau and Dr. Pal have indicated that they will not be discussing drugs that are off label or used for investigational purposes.This activity has been made possible in part by an unrestricted educational grant from Pfizer Inc.

 

 

Faculty

Faculty

Clayton Lau, M.D.
Clinical Assistant Professor of Surgery
Urology and Urologic Oncology
Department of Surgery
City of Hope














Sumanta Kumar Pal, M.D.
Assistant Professor of Medical Oncology
Department of Medical Oncology and Therapeutics Research
Co-Director, Kidney Cancer Program
City of Hope








Education and Training
As one of only a select few National Cancer Institute-designated Comprehensive Cancer Centers in the country, City of Hope integrates all aspects of cancer research, treatment and education. We offer a range of programs serving students, post-doctoral trainees, health and medical professionals.

City of Hope’s Irell & Manella Graduate School of Biological Sciences equips students with the skills and strategies to transform the future of modern medicine.
City of Hope has a long-standing commitment to Continuing Medical Education (CME), sharing advances in cancer research and treatment with the health-care community through CME courses such as conferences, symposia and other on and off campus CME opportunities for medical professionals.
Local and national conferences, in-depth educational training and a certification program provide both current and aspiring health professionals opportunities to further their knowledge in their fields of interest.
 
 
City of Hope offers a range of programs and services, such as Graduate Medical Education & Clinical Training, that serve students, post-doctoral trainees, medical professionals and staff.
The goal of the Postdoctoral Training Office is to ensure the postdoctoral experience at City of Hope is rewarding and meaningful to all participants.